Delay to Publication of Audited Results

/**/

RNS Number : 3047N Silverwood Brands PLC 31 December 2025  

31 December 2025   Silverwood Brands plc ("Silverwood" or the "Company"; together with its subsidiaries, the "Group)   Delay to Publication of Audited Results   Silverwood Brands plc (AQSE: SLWD), a holding company established to invest primarily in branded consumer businesses, announces that there has been a delay in completing the audit of the Group's results for the 18 month period ended 30 June 2025.   The delay arises from the additional time required to complete the audit of the Group's Japanese subsidiaries. This has been necessitated by the technically complex translation of subsidiary financial statements from Japanese Generally Accepted Accounting Principles ("Japanese GAAP") to International Financial Reporting Standards ("IFRS").   While the Group has previously audited and consolidated its Japanese subsidiaries, the Sonotas companies, the acquisition of Cosme Science during the period  introduced additional complexity to the current audit.   Temporary Suspension Accordingly, as the Company will be unable to publish  audited results by 31 December 2025 as required by Rule 4.3 of the Aquis Growth Market Access Rulebook, trading in the Company's ordinary shares will be temporarily suspended with effect from 08.00 on Friday, 2 January 2026.   Unaudited Financial Information For information purposes, limited unaudited financial information relating to the Group for the 18 month period ended 30 June 2025 is set out below.   This information has been extracted from the Company's draft report and accounts for the period ended 30 June 2025 and has not been audited. A further announcement will be released by the Company on completion of the audit and any material changes between the financial information set out below and the audited financial information will be disclosed in that announcement.  

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 









30 June 2025

 

31 December 2023

 







Assets

 







Non-Current Assets

 







Property, Plant and Equipment



9,151,299



199,306

Intangible Assets



18,266,219



23,594,130

Other Non-Current Investments



-



80

Trade and Other Receivables



-



-





27,417,518

 

23,793,516











Current Assets

 







Trade and Other Receivables



3,131,898



3,394,016

Inventories



2,493,049



1,727,768

Cash and Cash Equivalents



3,070,441



2,799,449





8,695,388

 

7,921,233











Total Assets

 

36,112,906

 

31,714,749

Liabilities

 







Non-Current Liabilities

 







Trade and Other Liabilities



878,334



1,996,367

Loans and Borrowings



7,588,104



1,264,449

Deferred Tax Liability



3,309,767



1,799,191





11,776,205

 

5,060,007











Current Liabilities

 







Trade and Other Liabilities



2,672,370



6,097,606

Loans and Borrowings



3,170,656



5,368,149

Provisions



398,970



286,282





6,241,996

 

11,752,037











Total Liabilities

 

18,018,201

 

16,812,044

 







Net Assets

 

18,094,705

 

14,902,705

    Issued capital and reserves attributable to owners of the parent

 







Share Capital



4,250,018



3,250,018

Share Premium



27,195,826



22,795,826

Shares to be Issued



378,969



831,450

Reverse Takeover Reserve



(2,014,193)



(4,797,432)

Shared Based Payments Reserve



4,377,444



6,110,807

Foreign Exchange Reserve



(508,956)



(421,716)

Retained Earnings



(15,533,691)



(12,815,536)





18,145,417

 

14,953,417











Non-Controlling Interests



(50,712)



(50,712)











Total Equity

 

18,094,705

 

14,902,705

   

CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME

 



18 Months Ended 30 June 2025

 

As Restated: 12 Months Ended 31 December 2023

 







Revenue

 

23,912,606

 

11,094,983

Cost of Sales



(10,177,871)



(1,680,895)

Gross Profit

 

13,734,735

 

9,414,088











Other Operating Income



24,479



26,799

Selling and Distribution



(1,723,467)



(1,112,392)

Administrative Expenses



(12,312,817)



(8,756,008)











EBITDA

 

(277,070)

 

(427,513)











Depreciation



(3,510,103)



(1,308,793)

Exceptional Costs



(4,159,939)



(219,644)

Fair Value Movements



668,283



-

Acquisition costs, acquisition related contingent considerations and earn-outs



4,262,631



(3,842,615)

Profit/(Loss) from Operations

 

(3,016,198)

 

(5,798,565)











Finance Income



43,498



41,649

Finance Expense



(1,111,406)



(805,786)

Profit/(Loss) Before Tax

 

(4,084,106)

 

(6,562,702)











Tax Expense



57,499



471,528

Profit/(Loss) for the period

 

(4,026,607)

 

(6,091,174)

 







Items that are or may be reclassified subsequently to profit or loss.

 

Exchange Loss Arising on Translation on Foreign Operations



(87,240)



(421,716)





(87,240)

 

(421,716)











Other Comprehensive Income for the Period, Net of Tax



(87,240)



(421,716)











Total Comprehensive Income

 

(4,113,847)

 

(6,512,890)











Loss for the period attributable to:

 







Owners of the Parent



(4,026,607)



(6,040,462)

Non-Controlling Interests



-



(50,712)





(4,026,607)

 

(6,091,174)











Total comprehensive income for the period attributable to:

 

Owners of the Parent



(4,113,847)



(6,462,178)

Non-Controlling Interests



-



(50,712)





(4,113,847)

 

(6,512,890)

    ENDS   For more information, please contact:  

Silverwood Brands plc



Andrew Gerrie

info@silverwoodbrands.com

Paul Hodgins



 



AlbR Capital Limited - Aquis Corporate Adviser

+44 (0)20 7469 0930





About Silverwood Brands plc Silverwood Brands  plc is a leader in the health and beauty industry, committed to developing and marketing high-quality products that meet the diverse needs of consumers worldwide. Through strategic acquisitions and organic growth, Silverwood Brands continues to enhance its portfolio and global reach, ensuring a strong position in the competitive health and beauty market.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  NEXGCBDDLUXDGUB